4.6 Article

Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 24, Pages 9370-9387

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.RA118.003278

Keywords

G protein-coupled receptor (GPCR); glucagon; receptor structure-function; cell signaling; site-directed mutagenesis; biased agonism; GLP-1 receptor; glucagon-like peptide-1; class B peptide hormone; ERK kinase; arrestin; transmembrane domain

Funding

  1. National Health and Medical Research Council of Australia [1061044, 1065410, 1126857]
  2. National Health and Medical Research Council [1055134]
  3. Shanghai Science and Technology Development Fund [15DZ2291600]
  4. National Natural Science Foundation of China [81573479]
  5. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020347, XDA12040308]
  6. Chinese Academy of Sciences
  7. National Health and Medical Research Council of Australia [1061044, 1065410, 1126857] Funding Source: NHMRC

Ask authors/readers for more resources

G protein-coupled receptors (GPCRs) can be differentially activated by ligands to generate multiple and distinct downstream signaling profiles, a phenomenon termed biased agonism. The glucagon-like peptide-1 receptor (GLP-1R) is a class B GPCR and a key drug target for managing metabolic disorders; however, its peptide agonists display biased signaling that affects their relative efficacies. In this study, we combined mutagenesis experiments and mapping of surface mutations onto recently described GLP-1R structures, which revealed two major domains in the GLP-1/GLP-1R/G(s) protein active structure that are differentially important for both receptor quiescence and ligand-specific initiation and propagation of biased agonism. Changes to the conformation of transmembrane helix (TM) 5 and TM 6 and reordering of extracellular loop 2 were essential for the propagation of signaling linked to cAMP formation and intracellular calcium mobilization, whereas ordering and packing of residues in TMs 1 and 7 were critical for extracellular signal-regulated kinase 1/2 (pERK) activity. On the basis of these findings, we propose a model of distinct peptide-receptor interactions that selectively control how these different signaling pathways are engaged. This work provides important structural insight into class B GPCR activation and biased agonism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists

Sanaz Darbalaei, Ru-lue Chang, Qing-tong Zhou, Yan Chen, An-tao Dai, Ming-wei Wang, De-hua Yang

Summary: The paradigm of one drug against multiple targets, known as unimolecular polypharmacology, has shown promising results in the treatment of type 2 diabetes and obesity by targeting two or three specific receptors. By studying agonist efficacy and signaling patterns, this study reveals the crucial residue networks involved in agonist-mediated receptor activation, providing insights for the rational design of biased drug leads.

ACTA PHARMACOLOGICA SINICA (2023)

Article Pharmacology & Pharmacy

Structure-activity relationship of pyrazol-4-yl- pyridine derivatives and identification of a radiofluorinated probe for imaging the muscarinic acetylcholine receptor M4

Ahmed Haider, Xiaoyun Deng, Olivia Mastromihalis, Stefanie K. Pfister, Troels E. Jeppesen, Zhiwei Xiao, Vi Pham, Shaofa Sun, Jian Rong, Chunyu Zhao, Jiahui Chen, Yinlong Li, Theresa R. Connors, April T. Davenport, James B. Daunais, Vahid Hosseini, Wenqing Ran, Arthur Christopoulos, Lu Wang, Celine Valant, Steven H. Liang

Summary: This study aimed to develop a suitable M4 PET ligand for the non-invasive visualization of M4 in the brain. The compound 12 was identified as a subtype-selective positive allosteric modulator (PAM) and its radiofluorinated analogue showed moderate specificity in rodent brain sections. However, in non-human primates and humans, the presence of carbachol did not improve the specificity and selectivity of the radioligand.

ACTA PHARMACEUTICA SINICA B (2023)

Article Biochemistry & Molecular Biology

Structural and Molecular Determinants for Isoform Bias at Human Histamine H3 Receptor Isoforms

Sabrina N. Rahman, Daniel A. McNaught-Flores, Yara Huppelschoten, Daniel da Costa Pereira, Arthur Christopoulos, Rob Leurs, Christopher J. Langmead

Summary: The human histamine H3 receptor is expressed in the CNS and regulates the synthesis and release of histamine and neurotransmitters. It is associated with CNS disorders and its isoforms display variations in intracellular loop 3. The mechanisms of biased agonism at these isoforms remain unknown.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Pharmacology & Pharmacy

Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Ye Jiang, Mahmuda Yeasmin, Arisbel B. Gondin, Arthur Christopoulos, Celine Valant, Wessel A. C. Burger, David M. Thal

Summary: This study investigated the activation of individual G protein subfamilies and downstream signaling pathways of compounds 6A and 7A at the M-2 mAChR. The results showed that M-2 mAChR primarily couples to Galpha(i/o) and Galpha(s), but no Galpha(i) bias was detected for compounds 6A and 7A. This highlights the importance of cellular background in classifying new ligands.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders

Ayame Saito, Sadia Alvi, Celine Valant, Arthur Christopoulos, Simona E. Carbone, Daniel P. Poole

Summary: The enteric nervous system plays a crucial role in regulating gastrointestinal motility. Disrupted enteric nervous system activity can lead to dysmotility. Pharmacological treatment options for dysmotility involve targeting G protein-coupled receptors (GPCRs) expressed by enteric nervous system neurons. Current drugs that target GPCRs for motility disorders have drawbacks such as significant side-effects and a loss of physiological tone. Allosteric modulation of GPCRs, which bind to a distinct site from the endogenous ligand, may provide effective relief from motility disorders while minimizing side-effects.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Review Endocrinology & Metabolism

New Insights into the Structure and Function of Class B1 GPCRs

Brian P. Cary, Xin Zhang, Jianjun Cao, Rachel M. Johnson, Sarah J. Piper, Elliot J. Gerrard, Denise Wootten, Patrick M. Sexton

Summary: G protein-coupled receptors (GPCRs), particularly the B1 class, play a critical role in maintaining homeostasis and are important drug targets. Recent advances in cryo-electron microscopy have provided valuable insights into the structure and dynamics of these receptors, which contribute to our understanding of their functions.

ENDOCRINE REVIEWS (2023)

Article Multidisciplinary Sciences

Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)

Yan Chen, Qingtong Zhou, Jiang Wang, Youwei Xu, Yun Wang, Jiahui Yan, Yibing Wang, Qi Zhu, Fenghui Zhao, Chenghao Li, Chuan-Wei Chen, Xiaoqing Cai, Ross A. . D. Bathgate, Chun Shen, H. Eric Xu, Dehua Yang, Hong Liu, Ming-Wei Wang

Summary: The authors reveal the ligand-binding modes and key determinants of peptidomimetic agonism and subtype selectivity through cryo-EM structures. This study provides insights into ligand recognition and subtype selectivity among class A G protein-coupled receptors, and expands the knowledge of signaling mechanisms in the insulin superfamily.

NATURE COMMUNICATIONS (2023)

Review Pharmacology & Pharmacy

The role of the adenosine system in epilepsy and its comorbidities

Jo-Anne Baltos, Pablo M. Casillas-Espinosa, Ben Rollo, Karen J. Gregory, Paul J. White, Arthur Christopoulos, Patrick Kwan, Terence J. O'Brien, Lauren T. May

Summary: Epilepsy, a serious neurological condition, affects millions of people worldwide. Current pharmacotherapy only successfully controls seizures in about 70% of epilepsy patients, and many suffer from psychiatric and physical comorbidities. Adenosine, a natural substance, has shown potential as an anti-epileptic agent through its receptor activation. Recent advances have also shown that adenosine receptors can modulate epilepsy-associated comorbidities. This review provides an accessible resource on the use of the adenosine system as a therapeutic target for epilepsy and its associated comorbidities.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Correction Biochemistry & Molecular Biology

Structural basis of efficacy-driven ligand selectivity at GPCRs (Feb, 10.1038/s41589-022-01247-5, 2023)

Alexander S. Powers, Vi Pham, Wessel A. C. Burger, Geoff Thompson, Yianni Laloudakis, Nicholas W. Barnes, Patrick M. Sexton, Steven M. Paul, Arthur Christopoulos, David M. Thal, Christian C. Felder, Celine Valant, Ron O. Dror

NATURE CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Structural basis of efficacy-driven ligand selectivity at GPCRs

Alexander S. Powers, Vi Pham, Wessel A. C. Burger, Geoff Thompson, Yianni Laloudakis, Patrick M. Sexton, Steven M. Paul, Arthur Christopoulos, David M. Thal, Christian C. Felder, Celine Valant, Ron O. Dror

Summary: The selectivity of a drug for target receptors is crucial but challenging when the receptors are similar. Serendipitous discovery of ligands that stimulate target receptors more strongly than closely related receptors provides a solution. This study reveals the structural basis for the efficacy-driven selectivity of xanomeline, a clinical drug candidate, between closely related muscarinic acetylcholine receptors (mAChRs), using atomic-level simulations. The results suggest strategies for rational design of ligands achieving efficacy-driven selectivity for G-protein-coupled receptors.

NATURE CHEMICAL BIOLOGY (2023)

Article Chemistry, Medicinal

Structure-based virtual screening discovers potent and selective adenosine A1 receptor antagonists

Pierre Matricon, Anh T. N. Nguyen, Duc Duy Vo, Jo-Anne Baltos, Mariama Jaiteh, Andreas Luttens, Stefanie Kampen, Arthur Christopoulos, Jan Kihlberg, Lauren Therese May, Jens Carlsson

Summary: A structure-based virtual screening approach was used to design subtype-selective ligands for A1 and A2A adenosine receptors. The study identified a non-conserved subpocket in the binding sites that could be exploited to identify A1R selective ligands. Computational screening predicted 20 A1R selective ligands, with 7 of them exhibiting micromolar activities against A1R. Further optimization resulted in antagonists with nanomolar potency and up to 76-fold A1R-selectivity. This study demonstrates the potential of structure-based virtual screening in guiding the discovery and optimization of subtype-selective ligands, enabling the development of safer drugs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

Wessel A. C. Burger, Vi Pham, Ziva Vuckovic, Alexander S. Powers, Jesse I. Mobbs, Yianni Laloudakis, Alisa Glukhova, Denise Wootten, Andrew B. Tobin, Patrick M. Sexton, Steven M. Paul, Christian C. Felder, Radostin Danev, Ron O. Dror, Arthur Christopoulos, Celine Valant, David M. Thal

Summary: The M4 muscarinic acetylcholine receptor is a significant drug target for the treatment of psychosis, cognition, and addiction. The clinical trial of xanomeline has shown promise in improving symptoms and the cryo-EM structure reveals the binding mechanism, providing insight into its complex pharmacology.

NATURE COMMUNICATIONS (2023)

Article Cell Biology

Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

Ping Luo, Wenbo Feng, Shanshan Ma, Antao Dai, Kai Wu, Xianyue Chen, Qingning Yuan, Xiaoqing Cai, Dehua Yang, Ming-Wei Wang, H. Eric Xu, Yi Jiang

Summary: G protein-coupled receptors (GPCRs) are regulated by accessory proteins such as melanocortin receptor accessory protein 1 (MRAP1), which plays a crucial role in the regulation of melanocortin receptor 2 (MC2R). The activation of MC2R by adrenocorticotropic hormone (ACTH) and its involvement in glucocorticoid biogenesis have significant effects on the hypothalamic-pituitary-adrenal axis and related disorders. This study presents the cryo-electron microscopy structure of the ACTH-bound MC2R-G(s)-MRAP1 complex, revealing the unique structure and stabilizing effect of MRAP1 on ACTH binding and MC2R activation. The findings provide insights into GPCR regulation and the design of therapeutic agents targeting MC2R.

CELL RESEARCH (2023)

Meeting Abstract Pharmacology & Pharmacy

Bias profile and efficacy-driven selectivity of xanomeline at the muscarinic acetylcholine receptor family

Celine Valant, Alexander Powers, Vi Pham, Wessel Burger, Emma van der Westhuizen, Nicholas Barnes, Steven Paul, Arthur Christopoulos, David Thal, Christian Felder, Ron Dror

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Low allosteric agonism and moderate modulation are required for optimal therapeutic window for positive allosteric modulators of the M1 muscarinic acetylcholine receptor

Huong Thi Mai Nguyen, Emma van der Westhuizen, Elham Khajehali, Arthur Christopoulos, Celine Valant

BRITISH JOURNAL OF PHARMACOLOGY (2023)

No Data Available